Torley Helen (CIK 0001528185)

Latest company ownership

Shares held
16,569
Last filed at
Dec 1, 2025
Confidence Score
33.7
2025Q4
Confidence Score History
2014Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 26, 2025 Dec 1, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -41,569 -1.16% ✓ $1.1M
Nov 10, 2025 Nov 12, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -60,000 -1.01% ✓ $4.2M
Oct 1, 2025 Oct 3, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -60,000 -0.73% ✓ $4.3M
Sep 2, 2025 Sep 4, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -60,000 -1.00% ✓ $4.4M
Aug 11, 2025 Aug 13, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -60,000 -1.34% ✓ $3.8M
Jul 8, 2025 Jul 10, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -60,000 -1.33% ✓ $3.4M
Jun 20, 2025 Jun 24, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -60,000 -1.99% ✓ $3.2M
Feb 23, 2025 Feb 24, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -12,081 -1.62% ✗ $697.7K
Feb 15, 2025 Feb 18, 2025 HALOZYME THERAPEUTICS, INC. CEO Sell 37.5 -66,166 -2.29% ✗ $3.9M
Oct 8, 2024 Oct 9, 2024 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -20,000 -0.59% ✓ $1.1M
Sep 24, 2024 Sep 26, 2024 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.46% ✓ $1.7M
Sep 10, 2024 Sep 12, 2024 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.46% ✓ $1.8M
Aug 13, 2024 Aug 15, 2024 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -30,000 -0.88% ✓ $1.7M
Feb 16, 2024 Feb 20, 2024 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -20,362 -1.49% ✗ $735.1K
Feb 15, 2024 Feb 16, 2024 HALOZYME THERAPEUTICS, INC. CEO Sell 85.0 +8,126 1.25% ✗ $885.4K
Feb 10, 2024 Feb 13, 2024 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -16,943 -2.59% ✗ $601.3K
Aug 29, 2023 Aug 31, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.58% ✓ $1.3M
Aug 15, 2023 Aug 17, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.58% ✓ $1.3M
Jul 25, 2023 Jul 27, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.58% ✓ $1.3M
Mar 7, 2023 Mar 9, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.58% ✓ $1.3M
Feb 16, 2023 Feb 21, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -11,061 -1.72% ✗ $544.9K
Feb 15, 2023 Feb 17, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -6,892 -1.09% ✗ $339.1K
Feb 10, 2023 Feb 14, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 37.5 -33,735 -2.69% ✗ $1.7M
Feb 7, 2023 Feb 9, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.67% ✓ $1.5M
Jan 17, 2023 Jan 19, 2023 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.26% ✓ $1.5M
Dec 13, 2022 Dec 15, 2022 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.01% ✓ $1.7M
Nov 15, 2022 Nov 17, 2022 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -30,000 -1.26% ✓ $1.6M
Feb 15, 2022 Feb 17, 2022 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -6,892 -1.16% ✗ $237.3K
Feb 10, 2022 Feb 14, 2022 HALOZYME THERAPEUTICS, INC. CEO Sell 37.5 -48,989 -2.80% ✗ $1.7M
Nov 8, 2021 Nov 8, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2M
Oct 4, 2021 Oct 4, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2M
Sep 7, 2021 Sep 7, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2.1M
Aug 10, 2021 Aug 10, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2.1M
Jul 6, 2021 Jul 6, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2.3M
Jun 7, 2021 Jun 7, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2M
May 11, 2021 May 11, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2.2M
Apr 5, 2021 Apr 5, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2.1M
Mar 1, 2021 Mar 1, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -8.52% ✓ $2.3M
Feb 22, 2021 Feb 22, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -19,511 -3.50% ✗ $950K
Feb 14, 2021 Feb 16, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -14,243 -2.68% ✗ $709.9K
Feb 10, 2021 Feb 12, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 37.5 -31,768 -3.11% ✗ $1.6M
Feb 1, 2021 Feb 1, 2021 HALOZYME THERAPEUTICS, INC. CEO Sell 23.8 -50,000 -9.61% ✓ $2.4M
Nov 25, 2020 Nov 25, 2020 HALOZYME THERAPEUTICS, INC. CEO Sell 17.5 -50,000 -9.42% ✗ $2M
Feb 22, 2020 Feb 24, 2020 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -19,511 -3.83% ✗ $425.9K
Feb 14, 2020 Feb 18, 2020 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -14,244 -2.94% ✗ $300.5K
Feb 12, 2020 Feb 13, 2020 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -16,259 -3.44% ✗ $325.2K
Feb 3, 2020 Feb 4, 2020 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -19,910 -4.33% ✗ $382.5K
Feb 22, 2019 Feb 22, 2019 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -19,511 -4.47% ✗ $328K
Feb 14, 2019 Feb 15, 2019 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -14,244 -3.47% ✗ $235.6K
Feb 6, 2019 Feb 6, 2019 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -14,547 -3.67% ✗ $243.4K
Feb 3, 2019 Feb 5, 2019 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -19,425 -5.05% ✗ $313.1K
Feb 22, 2018 Feb 23, 2018 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -19,511 -5.59% ✗ $376.2K
Feb 6, 2018 Feb 6, 2018 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -15,493 -4.77% ✗ $282.7K
Feb 3, 2018 Feb 5, 2018 HALOZYME THERAPEUTICS, INC. CEO Sell 40.0 -24,111 -7.58% ✗ $442.9K
Jan 6, 2018 Jan 9, 2018 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -11,649 -4.25% ✗ $226.7K
Jun 30, 2016 Jul 5, 2016 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -7,044 -5.24% ✗ $60.8K
Feb 6, 2016 Feb 9, 2016 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -11,743 -8.85% ✗ $92.8K
Jan 6, 2016 Jan 7, 2016 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -11,686 -10.33% ✗ $184.3K
Dec 31, 2015 Jan 4, 2016 HALOZYME THERAPEUTICS, INC. CEO Sell 97.5 +15,064 22.13% ✗ $284.8K
Jan 6, 2015 Jan 6, 2015 HALOZYME THERAPEUTICS, INC. CEO Sell 42.5 -11,919 -14.90% ✗ $119.9K
Sep 16, 2014 Sep 16, 2014 HALOZYME THERAPEUTICS, INC. CEO Buy 97.5 +50,000 100.00% ✗ $446K